玻璃体内注射雷珠单抗治疗脉络膜骨瘤继发脉络膜新生血管患者。 - Suppr

Suppr

超能文献

Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.

作者信息

Song M-h, Roh Y-j

出版信息

Eye (Lond). 2009 Aug;23(8):1745-6. doi: 10.1038/eye.2008.313. Epub 2008 Oct 24.

DOI:10.1038/eye.2008.313

PMID:18949006

Abstract

摘要

相似文献

Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.玻璃体内注射雷珠单抗治疗脉络膜骨瘤继发脉络膜新生血管患者。

Eye (Lond). 2009 Aug;23(8):1745-6. doi: 10.1038/eye.2008.313. Epub 2008 Oct 24.

Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.玻璃体内注射贝伐单抗治疗脉络膜骨瘤继发的脉络膜新生血管

Acta Ophthalmol. 2009 Feb;87(1):100-1. doi: 10.1111/j.1600-0420.2007.01136.x.

Retinal pigment epithelium tear formation following intravitreal ranibizumab injection in choroidal neovascularization secondary to choroidal osteoma.脉络膜骨瘤继发脉络膜新生血管接受玻璃体内注射雷珠单抗后视网膜色素上皮撕裂的形成

Cutan Ocul Toxicol. 2014 Sep;33(3):259-63. doi: 10.3109/15569527.2013.844702. Epub 2014 Feb 11.

Intravitreal ranibizumab for choroidal neovascularisation secondary to angioid streaks.玻璃体内注射雷珠单抗治疗血管样条纹继发的脉络膜新生血管。

Eye (Lond). 2009 Aug;23(8):1750-1. doi: 10.1038/eye.2009.158. Epub 2009 Jul 10.

Intravitreal ranibizumab for choroidal neovascularisation secondary to pathologic myopia: 12 month results.

Eye (Lond). 2010 Aug;24(8):1420; author reply 1420-1. doi: 10.1038/eye.2010.40. Epub 2010 Apr 30.

Intravitreal ranibizumab for choroidal neovascularisation in serpiginous choroiditis.玻璃体内注射雷珠单抗治疗匐行性脉络膜炎性脉络膜新生血管

Eye (Lond). 2009 Sep;23(9):1873-5. doi: 10.1038/eye.2008.346. Epub 2008 Nov 7.

Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy.眼内雷珠单抗治疗特发性脉络膜毛细血管炎继发黄斑区脉络膜新生血管的疗效观察。

Retina. 2010 Oct;30(9):1400-4. doi: 10.1097/IAE.0b013e3181d374dc.

[Intravitreal injection of bevacizumab for CNV secondary to choroidal osteoma and follow-up by Spectral-Domain OCT].玻璃体内注射贝伐单抗治疗脉络膜骨瘤继发的脉络膜新生血管并采用光谱域光学相干断层扫描进行随访

J Fr Ophtalmol. 2012 Sep;35(7):508-13. doi: 10.1016/j.jfo.2011.11.009. Epub 2012 Jun 12.

Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results.玻璃体腔雷珠单抗治疗病理性近视继发脉络膜新生血管：12 个月的结果。

Eye (Lond). 2009 Jun;23(6):1275-80; quiz 1281. doi: 10.1038/eye.2009.88. Epub 2009 May 29.

Choroidal neovascularization secondary to choroidal osteoma: successful treatment with photodynamic therapy.脉络膜骨瘤继发脉络膜新生血管形成：光动力疗法成功治疗

Eye (Lond). 2005 Apr;19(4):482-4. doi: 10.1038/sj.eye.6701475.

引用本文的文献

Secondary choroidal neovascularization due to choroidal osteoma after 9 years follow-up.随访 9 年后因脉络膜骨瘤导致的脉络膜新生血管。

BMC Ophthalmol. 2021 May 31;21(1):242. doi: 10.1186/s12886-021-02004-3.

Small Symptomatic Unilateral Choroidal Osteoma Diagnosed with Enhanced-Depth Imaging Optical Coherence Tomography and Thin-Slice Computed Tomography: 2 Clinical Cases.通过增强深度成像光学相干断层扫描和薄层计算机断层扫描诊断的小型有症状单侧脉络膜骨瘤：2例临床病例

Case Rep Ophthalmol. 2020 Jun 29;11(2):242-248. doi: 10.1159/000508846. eCollection 2020 May-Aug.

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab.雷珠单抗治疗脉络膜骨瘤及继发性脉络膜新生血管

Turk J Ophthalmol. 2017 Aug;47(4):243-246. doi: 10.4274/tjo.86658. Epub 2017 Aug 15.

Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization.玻璃体腔内注射贝伐单抗治疗无脉络膜新生血管的脉络膜骨瘤

J Ophthalmic Vis Res. 2015 Oct-Dec;10(4):484-6. doi: 10.4103/2008-322X.176905.

Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.玻璃体内注射贝伐单抗单药治疗脉络膜骨瘤继发的脉络膜新生血管。

Eye (Lond). 2016 Jun;30(6):843-9. doi: 10.1038/eye.2016.50. Epub 2016 Apr 1.

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.玻璃体内注射贝伐单抗治疗脉络膜骨瘤相关脉络膜新生血管的长期疗效。

Clin Ophthalmol. 2015 Mar 3;9:429-37. doi: 10.2147/OPTH.S78817. eCollection 2015.

Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.玻璃体内注射阿柏西普对脉络膜骨瘤继发脉络膜新生血管进行挽救治疗，此类患者对玻璃体内注射贝伐单抗和雷珠单抗无反应。

Int Ophthalmol. 2015 Jun;35(3):441-4. doi: 10.1007/s10792-015-0059-5. Epub 2015 Mar 12.

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma.玻璃体内注射抗血管内皮生长因子治疗脉络膜骨瘤所致脉络膜新生血管的作用

J Ophthalmol. 2014;2014:210458. doi: 10.1155/2014/210458. Epub 2014 Jul 23.

Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child.玻璃体内注射雷珠单抗治疗儿童骨瘤相关性脉络膜新生血管的长期结果

Oman J Ophthalmol. 2014 May;7(2):78-80. doi: 10.4103/0974-620X.137162.

Review of choroidal osteomas.脉络膜骨瘤综述。

Middle East Afr J Ophthalmol. 2014 Jul-Sep;21(3):244-50. doi: 10.4103/0974-9233.134686.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验